- E-mailLars.Herfindal@uib.no
- Phone+47 55 97 46 28+47 974 03 493
- Visitor AddressHaukeland universitetssykehus, Laboratoriebygget
- Postal AddressPostboks 78045020 Bergen
Academic article
- 2020. Sequential bortezomib and temozolomide treatment promotes immunological responses in glioblastoma patients with positive clinical outcomes: A phase 1B study. Immunity,Inflammation and Disease. 342-359.
- 2020. New CDK8 inhibitors as potential anti-leukemic agents – Design, synthesis and biological evaluation. Bioorganic & Medicinal Chemistry. 1-8.
- 2020. Cyclodextrin Complexation Studies as the First Step for Repurposing of Chlorpromazine . International Journal of Pharmaceutics.
- 2020. AXL is a driver of stemness in normal mammary gland and breast cancer. iScience. 1-40.
- 2019. Mice depleted for Exchange Proteins Directly Activated by cAMP (Epac) exhibit irregular liver regeneration in response to partial hepatectomy. Scientific Reports. 1-17.
- 2019. Dereplication of Natural Products with Antimicrobial and Anticancer Activity from Brazilian Cyanobacteria . Toxins. 1-17.
- 2019. Cytotoxic saponins and other natural products from flowering tops of Narthecium ossifragum L. Phytochemistry. 67-77.
- 2019. Characterization of the interaction of the antifungal and cytotoxic cyclic glycolipopeptide hassallidin with sterol-containing lipid membranes. Biochimica et Biophysica Acta - Biomembranes. 1510-1521.
- 2019. Anticancer activity in Planctomycetes. Frontiers in Marine Science. 10 pages.
- 2019. A novel poly-oxygenated flavone glucoside from aerial parts of the Brazilian plant Neoglaziovia variegata (Bromeliaceae). Heliyon. 1-13.
- 2019. A kinase inhibitor with anti-Pim kinase activity is a potent and selective cytotoxic agent toward acute myeloid leukemia. Molecular Cancer Therapeutics. 567-578.
- 2018. Stabilization of Human Tyrosine Hydroxylase in Maltodextrin Nanoparticles for Delivery to Neuronal Cells and Tissue. Bioconjugate chemistry. 493-502.
- 2018. Enhancement of iodinin solubility by encapsulation into cyclodextrin nanoparticles. Journal of Enzyme Inhibition and Medicinal Chemistry. 370-375.
- 2017. Total synthesis and antileukemic evaluations of the phenazine 5,10-dioxide natural products iodinin, myxin and their derivatives. Bioorganic & Medicinal Chemistry. 2285-2293.
- 2017. Epac1-deficient mice have bleeding phenotype and thrombocytes with decreased GPIbβ expression. Scientific Reports. 1-15.
- 2016. Zebrafish as a model system for characterization of nanoparticles against cancer. Nanoscale. 862-877.
- 2016. Toxic aromatic compounds from fruits of Narthecium ossifragum L. Phytochemistry. 76-85.
- 2016. Cyanobacteria as a source for novel anti-leukemic compounds. Current Pharmaceutical Biotechnology. 78-91.
- 2015. Synthesis and activities of new indolopyrrolobenzodiazepine derivatives toward acute myeloid leukemia cells. Bioorganic & Medicinal Chemistry. 7313-7323.
- 2015. Biologically active carbazole derivatives: focus on oxazinocarbazoles and related compounds. Journal of Enzyme Inhibition and Medicinal Chemistry. 180-188.
- 2014. Time-dependent inhibitory effects of cGMP-analogues on thrombin-induced platelet-derived microparticles formation, platelet aggregation, and P-selectin expression. Biochemical and Biophysical Research Communications - BBRC. 357-363.
- 2014. New N-1,N-10 bridged pyrrolo[2,3-α]carbazole-3-carbaldehydes: synthesis and biological activities. Bioorganic chemistry (Print). 108-115.
- 2014. Introduction of aromatic ring-containing substituents in cyclic nucleotides is associated with inhibition of toxin uptake by the hepatocyte transporters OATP 1B1 and 1B3. PLOS ONE.
- 2014. Efficacy of multi-functional liposomes containing daunorubicin and emetine for treatment of acute myeloid leukaemia. European journal of pharmaceutics and biopharmaceutics.
- 2014. Cyanobacteria from terrestrial and marine sources contain apoptogens able to overcome chemoresistance in acute myeloid leukemia cells. Marine Drugs. 2036-2053.
- 2014. Anti-microbial and cytotoxic 1,6-dihydroxyphenazine-5,10-dioxide (iodinin) produced by Streptosporangium sp. DSM 45942 isolated from the fjord sediment. Applied Microbiology and Biotechnology. 603-610.
- 2014. Adenosine content and growth in the diatom Phaeodactylum tricornutum (Bacillariophyceae): effect of salinity, light, temperature and nitrate. Diatom Research. 361-369.
- 2014. Adenosine content and growth in the diatom Phaeodactylum tricornutum (Bacillariophyceae): effect of salinity, light, temperature and nitrate. Diatom Research. 361-369.
- 2014. 4-methylproline guided natural product discovery: co-occurrence of 4-hydroxy- and 4-methylprolines in nostoweipeptins and nostopeptolides. ACS Chemical Biology. 2646-2655.
- 2013. Off-target effect of the Epac agonist 8-pCPT-2'-O-Me-cAMP on P2Y12 receptors in blood platelets. Biochemical and Biophysical Research Communications - BBRC. 603-608.
- 2013. Iodinin (1,6-dihydroxyphenazine 5,10-dioxide) from streptosporangium sp. induces apoptosis selectively in myeloid leukemia cell lines and patient cells. Marine Drugs. 332-349.
- 2013. Functional p53 is required for rapid restoration of daunorubicin-induced lesions of the spleen. BMC Cancer.
- 2013. Cyclic AMP can promote APL progression and protect myeloid leukemia cells against anthracycline-induced apoptosis. Cell Death & Disease.
- 2012. The lipopeptide toxins Anabaenolysin A and B target biological membranes in a cholesterol-dependent manner. Biochimica et Biophysica Acta - Biomembranes. 3000-3009.
- 2012. Anabaenolysins, novel cytolytic lipopeptides from benthic anabaena cyanobacteria. PLOS ONE.
- 2011. The apoptosis-inducing activity towards leukemia and lymphoma cells in a cyanobacterial culture collection is not associated with mouse bioassay toxicity. Journal of Industrial Microbiology & Biotechnology. 489-501.
- 2011. Nostocyclopeptide-M1: A potent, nontoxic inhibitor of the hepatocyte drug transporters OATP1B3 and 1B1. Molecular Pharmaceutics. 360-367.
- 2010. Marine Benthic Cyanobacteria Contain Apoptosis-Inducing Activity Synergizing with Daunorubicin to Kill Leukemia Cells, but not Cardiomyocytes. Marine Drugs. 2659-2672.
- 2010. A novel cyanobacterial nostocyclopeptide is a potent antitoxin against microcystins. ChemBioChem. 1594-1599.
- 2009. Marine Benthic Diatoms Contain Compounds Able to Induce Leukemia Cell Death and Modulate Blood Platelet Activity. Marine Drugs. 605-623.
- 2009. Biosynthesis of Macrolactam BE-14106 involves two distinct PKS systems and amino acid processing enzymes for generation of the aminoacyl starter unit. Chemistry and Biology. 1109-1121.
- 2009. Acyloxymethyl esterification of Nodularin-R and Microcystin-LA produces inactive protoxins that become reactivated and produce apoptosis inside intact cells. Journal of Medicinal Chemistry. 5758-5762.
- 2008. Antimicrobial and cytotoxic assessment of marine cyanobacteria - Synechocystis and synechococcus. Marine Drugs. 1-11.
- 2006. CaM-kinasell-dependent commitment to microcystin-induced apoptosis is coupled to cell budding, but not to shrinkage or chromatin hypercondensation. Cell Death and Differentiation. 1191-1202.
- 2005. Neuro-apoptogenic and blood platelet targeting toxins in benthic marine cyanobacteria from the Portuguese coast. Aquatic Toxicology. 294-306.
- 2005. A high proportion of Baltic Sea benthic cyanobacterial isolates contain apoptogens able to induce rapid death of isolated rat hepatocytes. Toxicon. 252-260.
- 2002. Use of marine toxins in combination with cytotoxic drugs for induction of apoptosis in acute myelogenous leukaemia cells. Expert Opinion on Biological Therapy. 197-210.
- 2001. Alterations in platelet phospholipid metabolism by substances from a marine microalgae. Chemistry and Physics of Lipids. 139-140.
Report
- 2005. The cAMP Receptors Epac and PKA synergize to induce PC12 cell neuritogenesis and to protect against apoptosis. .
Academic lecture
- 2017. Rome –en unik kilde til nye antileukemi naturprodukter.
- 2017. Isolation and screening of novel planctomycetes from Svarthamar ice Cave, Northern Norway.
- 2011. Bioactive compounds from culturable marine microorganisms.
- 2003. Drug potentials from marine cyanobacteria and microalgae from Norwegian waters.
- 2002. New apoptosis-modulating substances from marine microalgae.
- 2002. Bioactive compounds from cyanobacteria.
- 1999. Effect of feeding Artemia enriched with free phenylalanine and tyrosine to larval Japanese flounder.
Editorial
- 2016. Toward personalized treatment for acute myeloid leukemia. Current Pharmaceutical Biotechnology. 4-5.
- 2016. Editorial: Toward Personalized Treatment for Acute Myeloid Leukemia. Current Pharmaceutical Biotechnology. 4-5.
Short communication
- 2019. Short communication: Distribution of psychotropic drugs into lipoproteins. Therapeutic Drug Monitoring. 766-771.
Masters thesis
- 2020. Zebrafish Larvae as a Model to Study Doxorubicin-Induced Cardiotoxicity.
- 2020. Drug transport in blood: Lipoproteins as transporters of psychotropic drugs.
- 2019. Zebrafish Larvae as a Model to Study Doxorubicin-Induced Cardiotoxicity.
- 2019. Antileukemia activity of plant natural products and hemisynthetic analogs.
- 2016. The production and characterization of drug-loaded liposomal and PLGA nanocarriers for targeted treatment of acute myeloid leukemia.
- 2016. The efficiency of maltodextrin and porous silicon nanoparticles for the in vitro and in vivo stabilization of tyrosine hydroxylase.
- 2015. The role of Epac1 in endothelial barrier function Fluorescence intensity measurements of nano capsules in Wnt1-induced breast cancer.
- 2012. In vivo biodistribution of fluorescent nanocolloids intended for drug delivery. Evaluation of PEGylation state and fluorophore incorporation approach.
- 2012. In vitro validation of multifunctional liposomes for leukaemia and prostate cancer therapy ¿ the folate receptor and the prostate-specific membrane antigen as targets for drug delivery.
- 2008. Platelet inhibitory compounds from marine microorganisms.
- 2008. Bioactive compounds from marine microorganisms: search for anti-leukemic drugs and finding mechanisms of action.
Popular scientific article
- 2012. Nanokolloidar som verkty for å betra distribusjon av legemiddel. Naturen. 103-110.
- 2004. Havet som apotek. Naturen. 15-24.
- 2000. Anrikning av vannløselige komponenter i Artemia. Norsk Fiskeoppdrett. 26-27.
Doctoral dissertation
- 2006. Apoptosis modulating and anti-thrombotic activities from marine micro-organisms.
Interview
- 2019. Mikrobejakten. Langt inne i en isgrotte i Nordland har forskerne lett ettr ny antibiotika. Det haster å hente ut ukjente bakteriestammer, for verdens minste organismer står if are for å smelte bort.
Academic chapter/article/Conference paper
- 2007. Serine/Threonine Protein Phosphatases in Apoptosis. 16 pages.
Abstract
- 2013. Development and in vitro efficacy of liposomes carrying anthracyclines and emetine for enhanced therapeutic effect. The FEBS Journal. 322-322.
- 2008. Bioactive peptides from cyanobacteria. Journal of Peptide Science. 93-93.
Poster
- 2019. Preparation of non-oxidized graphene nanosheets for drug delivery.
- 2016. Total synthesis and initial antileukemic evaluation of the phenazine 5,10-dioxide natural products iodinin and myxin.
- 2015. Indeno[1,2-b]indole derivatives as protein kinase CK2 inhibitors: comparison of in silico models for Tox prediction.
- 2012. Development and in vitro efficacy of liposomes carrying anthracyclines and emetine for enhanced therapeutic effect.
- 2011. Characterization of cytotoxic activities in extracts from two marine invertebrates.
- 2010. Liver specific transporters of microcystins as a tool to find novel inhibitors of OATP1B1 and OATP1B3.
- 2009. The biosynthesis of macrolactam BE-14106: a new way of generating an aminoacyl starter unit.
- 2005. Searching cyanobacteria and microalgae from Norwegian waters for drug candidates.
- 2002. Effects of a new bioactive substance from a marine microalga on mammalian cells.
- 2001. TWO NOVEL APOPTOSIS-MODULATION SUBSTANCES ISOLATED FROM MARINE MICRO-ALGAE.
- 2001. New apoptosis-modulating substances from marine microalgae.
Academic literature review
- 2019. Immunoliposomes in acute myeloid leukaemia therapy. An overview of possible targets and obstacles. Current Medicinal Chemistry. 5278-5292.
- 2016. The use of nanocarriers in acute myeloid leukaemia therapy: Challenges and current status. Current Pharmaceutical Biotechnology. 30-41.
- 2015. Cell Death inducing microbial protein phosphatase inhibitors-mechanisms of action. Marine Drugs. 6505-6520.
- 2006. Microcystin produces disparate effects on liver cells in a dose dependent manner. Mini-Reviews in Medicinal Chemistry. 279-285.
More information in national current research information system (CRIStin)
Fields of competence